US 7,524,503 B2
	Human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor
Rajiv Khanna, Herston (Australia); Rebecca Ann Elkington, Manly (Australia); and Susan Jennifer Walker, Taringa (Australia)
Assigned to The Council of the Queensland Institute of Medical Research, Herston, Queensland (Australia)
Appl. No. 10/482,284 PCT Filed Jun. 26, 2002, PCT No. PCT/AU02/00829 § 371(c)(1), (2), (4) Date Apr. 13, 2004, PCT Pub. No. WO03/000720, PCT Pub. Date Jan. 03, 2003.
Claims priority of application No. PR 5931 (AU), filed on Jun. 26, 2001.
Prior Publication US 2005/0019344 A1, Jan. 27, 2005
Int. Cl. A61K 39/245 (2006.01); C07K 7/06 (2006.01); C12Q 1/70 (2006.01)

U.S. Cl. 424—186.1  [424/230.1; 530/328; 435/5]

10 Claims

1. An isolated peptide comprising a cytotoxic T-lymphocyte (CTL) epitope of a pp50 antigen of a cytomegalovirus of humans (HCMV) wherein said peptide consists of the amino acid sequence set forth in SEQ ID NO:165.